华康股份拟转让宁波中药988.09万股股份

Core Viewpoint - Huakang Co., Ltd. plans to transfer its 9,880,900 shares in Ningbo Traditional Chinese Medicine Pharmaceutical Co., Ltd. for a total consideration of 24.8998 million yuan, resulting in the company no longer holding any shares in Ningbo Traditional Chinese Medicine after the transfer [1]. Group 1 - The share transfer is part of the company's strategic development and operational adjustments to optimize its business structure [1]. - The company asserts that this transfer will not affect its normal production and operations [1]. - The financial status and operating results of the company will not be significantly impacted by this share transfer [1].